Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patients

被引：65

作者：

Courter, SG ^{[1
]}

Bedrosian, CL ^{[1
]}

机构：

[1] Genet Inst Inc, Cambridge, MA 02140 USA

来源：

SEMINARS IN HEMATOLOGY | 2001年 / 38卷 / 02期

关键词：

D O I：

10.1053/shem.2001.26299

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：52 / 59

页数：8

共 18 条

[1] FREQUENCY OF INHIBITOR DEVELOPMENT IN HEMOPHILIACS TREATED WITH LOW-PURITY FACTOR-VIII [J].

ADDIEGO, J ;

KASPER, C ;

ABILDGAARD, C ;

HILGARTNER, M ;

LUSHER, J ;

GLADER, B ;

ALEDORT, L .

LANCET, 1993, 342 (8869) :462-464

[2] INVITRO AND INVIVO CHARACTERIZATION OF FACTOR-VIII PREPARATIONS [J].

ALLAIN, JP ;

VERROUST, F ;

SOULIER, JP .

VOX SANGUINIS, 1980, 38 (02) :68-80

[3]

Biggs R, 1978, TREATMENT HAEMOPHILI, P110

[4]

BRAY GL, 1994, BLOOD, V83, P2428

[5] INCIDENCE OF DEVELOPMENT OF FACTOR-VIII AND FACTOR-IX INHIBITORS IN HEMOPHILIACS [J].

EHRENFORTH, S ;

KREUZ, W ;

SCHARRER, I ;

LINDE, R ;

FUNK, M ;

GUNGOR, T ;

KRACKHARDT, B ;

KORNHUBER, B .

LANCET, 1992, 339 (8793) :594-598

[6]

GRUPPO R, 1996, HEMOPHILIA S1, V2, P37

[7]

GRUPPO R, 1997, THROMB HAEMOST S

[8]

KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P869

[9] RECOMBINANT FACTOR-VIII FOR THE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - SAFETY, EFFICACY, AND DEVELOPMENT OF INHIBITORS [J].

LUSHER, JM ;

ARKIN, S ;

ABILDGAARD, CF ;

SCHWARTZ, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (07) :453-459

[10]

LUSHER JM, 1990, SEMIN HEMATOL, V27, P1

← 1 2 →